DermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The Importance of Early Intervention for Psoriatic Arthritis
The Importance of Early Intervention for Psoriatic Arthritis
Psoriatic Arthritis
The Importance of Early Intervention for Psoriatic Arthritis
- G. Michael Lewitt, MD
In The Pipeline: Phase 1, 2, and 3
In The Pipeline: Phase 1, 2, and 3
Psoriasis
In The Pipeline: Phase 1, 2, and 3
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
Psoriasis
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
- Jashin J. Wu, MD, FAAD
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
Psoriasis
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
- Jashin J. Wu, MD, FAAD
- Alexander Egeberg
- Priya Vedula Engel, MPH
- Sogol S. Javadi, BS
- Michael Korin
- Brandon Smith, BA